HomeCPRX • NASDAQ
add
Catalyst Pharmaceuticals Inc
Previous close
$19.82
Day range
$19.26 - $19.96
Year range
$11.56 - $20.87
Market cap
2.33B USD
Avg Volume
1.07M
P/E ratio
36.74
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 122.71M | 23.23% |
Operating expense | 52.66M | 30.06% |
Net income | 40.79M | 8.03% |
Net profit margin | 33.24 | -12.34% |
Earnings per share | 0.56 | 69.70% |
EBITDA | 63.68M | 15.22% |
Effective tax rate | 26.88% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 375.69M | 110.13% |
Total assets | 706.36M | 59.13% |
Total liabilities | 97.70M | 42.42% |
Total equity | 608.66M | — |
Shares outstanding | 118.69M | — |
Price to book | 3.86 | — |
Return on assets | 20.05% | — |
Return on capital | 23.05% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 40.79M | 8.03% |
Cash from operations | 64.14M | 108.54% |
Cash from investing | -10.00K | — |
Cash from financing | 1.16M | 640.65% |
Net change in cash | 65.28M | 113.76% |
Free cash flow | 55.94M | 120.88% |
About
Founded
2002
Headquarters
Website
Employees
167